“…Furthermore, SMAMPs exhibit significant advantages over natural AMPs, such as enhanced antimicrobial activity, flexible framework for chemical modification, improved physicochemical stability, and better compatibility with drug-delivery methodology 53 . Recently, unnatural antibacterial peptidomimetics of various backbone structure have emerged with promising potential, such as poly( α -amino acid)s 54 , 55 , 56 , 57 , poly( β -amino acid)s 58 , 59 , polymethacrylate 60 , 61 , 62 , polymethacrylamide 63 , 64 , poly(2-oxazoline) 65 , 66 , polycarbonates 67 , 68 , polynorbornene 69 , 70 , peptidopolysaccharides 41 , 71 , poly(isobutylene- alt-N -alkyl maleimide) 72 , 73 , 74 , β -peptides 75 , peptoids, and AApeptides 76 , 77 , 78 , 79 , 80 . The antibacterial performance of these MDPs is primarily affected by factors, such as amphiphilicity, charge, cationic chemical functionality, molecular weight, sequence, biodegradability, and subunit stereoisomerism.…”